NCCN Affiliate Research Consortium Offers Community Cancer Centers Cutting-Edge Research Opportunities
The NCCN Oncology Research Program (ORP) has established the NCCN Affiliate Research Consortium (ARC). The NCCN ARC’s primary goal is to maximize collaboration between NCCN Member Institutions and their affiliate research investigators to foster innovative research.
“The formation of the NCCN Affiliate Research Consortium is a monumental step in establishing a bridge between academic and community research centers,” said Diane E. Paul, MS, RN, Vice President, NCCN ORP. “The diverse expertise of researchers from academic institutions and community affiliates will result in faster completion of clinical trials and improved outcomes for patients with cancer.”
Previously known as the NCCN Affiliate Research Project, the pilot program was established in 2010 by NCCN’s Affiliate Forum to provide affiliates of the 23 NCCN Member Institutions access to cutting-edge research opportunities. Since that time, the program identified and approved a select group of qualified community sites and has evolved into a consortium that addresses the growing need for community research.
Current NCCN ARC objectives include identifying funding sources that support and promote the mission of the consortium, including the utilization of resources available for collaborative and efficient undertaking of research efforts. Additionally, ARC encourages the development of new investigators and inter-institutional infrastructures to support the research agenda. The NCCN ORP provides the operational infrastructure for the consortium.
Affiliates within the NCCN ARC include Northside Hospital Cancer Institute and Medical Center of Central Georgia, affiliates of University of Alabama at Birmingham Comprehensive Cancer Center; AtlantiCare Cancer Care Institute, Inspira Health Network (formerly South Jersey Healthcare), and Virtua, affiliates of Fox Chase Cancer Center; Bozeman Deaconess Hospital, MultiCare Health System, and Wenatchee Valley Medical Center, affiliates of Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; and Lehigh Valley Health Network and Norton Cancer Institute, affiliates of Moffitt Cancer Center.
For more information about the NCCN ARC, visit NCCN.org.
NCCN Releases New Translations of NCCN Guidelines
NCCN recently posted new translations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Hodgkin Lymphoma, Multiple Myeloma, Non-Hodgkin’s Lymphomas, and Prostate Cancer in Chinese, Korean, Portuguese, and Spanish.
Currently, more than 40 translations of select NCCN Guidelines and related content are available in the following languages: Bahasa Indonesia, Portuguese, Chinese, Japanese, Spanish, Korean, and Turkish. To access these resources, please visit NCCN.org.
If you would like to learn more about translations, regional adaptations of the NCCN Guidelines, or other international programming opportunities, please contact Jonathan Larsen, MPP, Manager, Global Business Development, at Larsen@nccn.org.
